Overview
Anita Deshpande is a Hematologist Oncology specialist and an Oncologist in Fayetteville, North Carolina. Dr. Deshpande is rated as an Experienced provider by MediFind in the treatment of Chronic Myelomonocytic Leukemia (CMML). Her top areas of expertise are Pleuropulmonary Blastoma, Squamous Cell Lung Carcinoma, Acute Mountain Sickness, Hemochromatosis, and Bone Marrow Aspiration. Dr. Deshpande is currently accepting new patients.
Her clinical research consists of co-authoring 6 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE ASSISTANCE PROGRAM
- MEDICARE MAPD
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
Locations
1638 Owen Dr, Fayetteville, NC 28304
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Ellen Willard is a Hematologist Oncology specialist and a Hematologist in Pinehurst, North Carolina. Dr. Willard is rated as a Distinguished provider by MediFind in the treatment of Chronic Myelomonocytic Leukemia (CMML). Her top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Richter Syndrome, and Chronic Myelomonocytic Leukemia (CMML). Dr. Willard is currently accepting new patients.
University Of North Carolina At Chapel Hill
Joshua Zeidner is a Hematologist Oncology specialist and a Hematologist in Chapel Hill, North Carolina. Dr. Zeidner is rated as an Elite provider by MediFind in the treatment of Chronic Myelomonocytic Leukemia (CMML). His top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Zeidner is currently accepting new patients.
Rex Hospital Inc
Alan Kritz is a Hematologist Oncology specialist and a Hematologist in Raleigh, North Carolina. Dr. Kritz is rated as a Distinguished provider by MediFind in the treatment of Chronic Myelomonocytic Leukemia (CMML). His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Multiple Myeloma, and Paget Disease of the Breast. Dr. Kritz is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Hepatic Porphyria (AHP)Dr. Deshpande isAdvanced. Learn about Acute Hepatic Porphyria (AHP).
- Acute Mountain SicknessDr. Deshpande isAdvanced. Learn about Acute Mountain Sickness.
- ALK-Positive Non-Small Cell Lung CancerDr. Deshpande isAdvanced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Antiphospholipid SyndromeDr. Deshpande isAdvanced. Learn about Antiphospholipid Syndrome.
- Childhood Iron Deficiency AnemiaDr. Deshpande isAdvanced. Learn about Childhood Iron Deficiency Anemia.
- Colorectal CancerDr. Deshpande isAdvanced. Learn about Colorectal Cancer.
- Experienced
- Acute Intermittent PorphyriaDr. Deshpande isExperienced. Learn about Acute Intermittent Porphyria.
- Adult Soft Tissue SarcomaDr. Deshpande isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Deshpande isExperienced. Learn about Agranulocytosis.
- Anal CancerDr. Deshpande isExperienced. Learn about Anal Cancer.
- AnemiaDr. Deshpande isExperienced. Learn about Anemia.
- AngiosarcomaDr. Deshpande isExperienced. Learn about Angiosarcoma.